Person:
MELETLİ, FURKAN

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

MELETLİ

First Name

FURKAN

Name

Filters

20242
Reset filters

Settings

Has files: true × Subject: Chemistry ×

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    PublicationOpen Access
    Investigation of the Interaction of Monoamine Oxidase (MAO) Inhibitor Biscoumarins with Hemoglobin and Albumin Using Multi-Spectroscopic Techniques and Molecular Docking
    (2024-01-01) MELETLİ, FURKAN; DANIŞ, ÖZKAN; Mutafoğlu B. S., MELETLİ F., DANIŞ Ö.
    Coumarin and their derivatives, such as biscoumarins, which are found as active ingredients in a variety of drugs, possess a wide range of biological activities. In this paper, the inhibitory effects of biscoumarin derivatives B1 and B2 on monoamine oxidase (MAO) enzyme activity were studied. Their binding mechanism to bovine serum hemoglobin (BHb) and bovine serum albumin (BSA) was investigated using molecular docking and multi-spectroscopic methods such as absorption, fluorescence, and synchronized fluorescence spectroscopy. The fluorescence quenching processes were analyzed using the Stern-Volmer, Lineweaver-Burk, and Hill methods. In this regard, Stern-Volmer quenching constants (Ksv), Lineweaver-Burk constants (KLB), and binding constants (Ka) were calculated at three temperatures (298, 310 and 322 K). The fluorescence studies showed that the binding of biscoumarins to BHb or BSA was a driven by static quenching. The Ka values of B2 to BHb and BSA (2179.11 and 18453.98 x 105 M-1) was larger than B1 at corresponding temperature (62.75 and 599.90 x105 M-1 for BHb and BSA, respectively), which indicates that the affinity of B2 toward the proteins were higher than that of B1. Moreover, thermodynamic parameters explained that hydrogen bonds were the main binding force stabilizing the protein-ligand complexes. Additionally, molecular docking studies have revealed binding energies, ligand efficiency values, and interactions with amino acid residues of proteins. The results of these investigations may be helpful in analyzing drug-protein binding of biscoumarins for potential future applications.
  • Thumbnail Image
    PublicationOpen Access
    Design, synthesis and biological evaluation of novel benzocoumarin derivatives as potent inhibitors of MAO-B activity
    (2024-11-15) MELETLİ, FURKAN; DEMİR, SERAP; DANIŞ, ÖZKAN; MELETLİ F., Gündüz C., Alparslan M. M., ATTAR A., DEMİR S., İskit E., DANIŞ Ö.
    The continued research of novel reversible inhibitors targeting monoamine oxidase (MAO) B remains crucial for effectively symptomatic treatment of Parkinson\"s disease. In this study we synthesized and evaluated a new series of 3-aryl benzo[g] and benzo[h] coumarin derivatives as MAO-B inhibitors. Compound A6 has been found to display the most potent inhibitory activity and selectivity against the MAO-B isoform (IC50 = 13 nM and SI = >7693.31 respectively). Inhibition mode of A6 on MAO-B was predicted as mixed reversible inhibition with a Ki value of 3.274 nM. Furthermore, in order to elaborate structure–activity relationships, the binding mode of A6 was investigated by molecular docking simulations.